PLD

124.47

-1.5%↓

SNOW

270.91

+0.91%↑

DLR

171.15

-2.15%↓

CBG

156.56

-2.82%↓

CCI

93.92

+1.67%↑

PLD

124.47

-1.5%↓

SNOW

270.91

+0.91%↑

DLR

171.15

-2.15%↓

CBG

156.56

-2.82%↓

CCI

93.92

+1.67%↑

PLD

124.47

-1.5%↓

SNOW

270.91

+0.91%↑

DLR

171.15

-2.15%↓

CBG

156.56

-2.82%↓

CCI

93.92

+1.67%↑

PLD

124.47

-1.5%↓

SNOW

270.91

+0.91%↑

DLR

171.15

-2.15%↓

CBG

156.56

-2.82%↓

CCI

93.92

+1.67%↑

PLD

124.47

-1.5%↓

SNOW

270.91

+0.91%↑

DLR

171.15

-2.15%↓

CBG

156.56

-2.82%↓

CCI

93.92

+1.67%↑

Search

Alexandria Real Estate Equities Inc

Open

SectorReal estate

59.34 -8.5

Overview

Share price change

24h

Current

Min

59.04

Max

65.65

Key metrics

By Trading Economics

Income

-101M

-62M

Sales

19M

762M

P/E

Sector Avg

102.987

84.443

Dividend yield

6.79

Profit margin

-8.161

Employees

552

EBITDA

55M

487M

Recommendations

By TipRanks

Recommendations

Neutral

12 Months Forecast

+14.46% upside

Dividends

By Dow Jones

Dividend yield

Sector Avg

6.79%

5.84%

Market Stats

By TradingEconomics

Market Cap

-246M

13B

Previous open

67.84

Previous close

59.34

News Sentiment

By Acuity

86%

14%

181 / 189 Real estate

Technical Score

By Trading Central

Confidence

Bearish Evidence

Alexandria Real Estate Equities Inc Chart

Past performance is not a reliable indicator of future results.

Related News

28 Oct 2025, 23:50 UTC

Hot Stocks

Stocks to Watch: Caesars, Enphase, Mondelez, Teradyne

28 Oct 2025, 23:25 UTC

Earnings

SK Hynix Posts Record Earnings on Continued AI-Chip Demand

28 Oct 2025, 23:18 UTC

Earnings

Booking 3Q Sales Rise as U.S. Travel Demand Stabilizes -- Update

28 Oct 2025, 22:20 UTC

Earnings

Visa Sales Jump as Consumers Keep Spending -- 2nd Update

28 Oct 2025, 22:13 UTC

Earnings

Wal-Mart de Mexico Net Profit Falls in 3Q

28 Oct 2025, 21:38 UTC

Earnings

Correction to Visa Sales Jump Article

28 Oct 2025, 21:17 UTC

Earnings

OrthoPediatrics Wins FDA Approval for Surgery Plating System; 3Q Revenue Rises

28 Oct 2025, 21:07 UTC

Earnings

Visa Sales Jump as Consumers Keep Spending -- Update

28 Oct 2025, 21:02 UTC

Earnings

Mondelez Tempers Outlook as Costs Rise

28 Oct 2025, 23:51 UTC

Market Talk

Nikkei May Rise on Easing U.S.-China Tensions -- Market Talk

28 Oct 2025, 23:42 UTC

Market Talk

Gold Edges Lower on Possible Position Adjustments Ahead of FOMC Decision -- Market Talk

28 Oct 2025, 23:02 UTC

Earnings

SK Hynix: HBM4 Shipments to Start in 4Q, Ahead of Full-Scale Sales Expansion in 2026

28 Oct 2025, 23:01 UTC

Earnings

SK Hynix: Completed Discussions With Key Customers About 2026 HMB Supply

28 Oct 2025, 22:46 UTC

Earnings

SK Hynix: Co. Secured Full Customer Demand for Its Entire DRAM and NAND Production for Next Yr >000660.SE

28 Oct 2025, 22:45 UTC

Earnings

SK Hynix 3Q Net KRW12.6T >000660.SE

28 Oct 2025, 22:44 UTC

Earnings

SK Hynix 3Q Rev KRW24.44T >000660.SE

28 Oct 2025, 22:43 UTC

Earnings

SK Hynix 3Q Net Profit Beat FactSet-Compiled Consensus

28 Oct 2025, 22:42 UTC

Earnings

SK Hynix 3Q Net KRW12.598T Vs. Net KRW5.753T >000660.SE

28 Oct 2025, 22:40 UTC

Earnings

SK Hynix 3Q Rev KRW24.449T Vs. KRW17.573T >000660.SE

28 Oct 2025, 22:40 UTC

Earnings

SK Hynix 3Q Oper Pft KRW11.383T Vs. Pft KRW7.030T >000660.SE

28 Oct 2025, 22:22 UTC

Earnings

Pharmaron Beijing: Higher Contributions From Clinical-Development Services Supported Results >300759.SZ

28 Oct 2025, 22:22 UTC

Earnings

Pharmaron Beijing: Higher Contributions From Laboratory Services Supported Results >300759.SZ

28 Oct 2025, 22:22 UTC

Earnings

Pharmaron Beijing 3Q Net CNY439.52M, Up 42.5% on Year >300759.SZ

28 Oct 2025, 22:20 UTC

Earnings

Pharmaron Beijing 3Q Rev CNY3.64B, Up 13.4% on Year >300759.SZ

28 Oct 2025, 22:02 UTC

Earnings

Review & Preview: Earnings Extravaganza -- Barrons.com

28 Oct 2025, 21:42 UTC

Market Talk
Earnings

Global Equities Roundup: Market Talk

28 Oct 2025, 21:42 UTC

Market Talk
Earnings

Mondelez Says Cocoa Costs Peaked Heading Into Spooky Season -- Market Talk

28 Oct 2025, 21:20 UTC

Earnings

Wal-Mart de Mexico 3Q EBITDA MXN25.27B, Up 3.3% on Year

28 Oct 2025, 21:19 UTC

Earnings

Wal-Mart de Mexico 3Q Rev MXN241.52B, Up 4.9% on Year

28 Oct 2025, 21:18 UTC

Earnings

Wal-Mart de Mexico 3Q Net MXN11.75B, Down 9.2% on Year

Peer Comparison

Price change

Alexandria Real Estate Equities Inc Forecast

Price Target

By TipRanks

14.46% upside

12 Months Forecast

Average 89.13 USD  14.46%

High 130 USD

Low 42 USD

Based on 9 Wall Street analysts offering 12 month price targets forAlexandria Real Estate Equities Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Neutral

9 ratings

3

Buy

5

Hold

1

Sell

Technical Score

By Trading Central

73.42 / 75.585Support & Resistance

Short Term

Bearish Evidence

Intermediate Term

No Evidence

Long Term

No Evidence

Sentiment

By Acuity

181 / 189 Real estate

News Sentiment

Very Strong Bearish Evidence

Volatility

Below average

News Volume (RCV)

Above average

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About Alexandria Real Estate Equities Inc

Alexandria Real Estate Equities, Inc. (NYSE: ARE), an S&P 500 company, is a best-in-class, mission-driven life science REIT making a positive and lasting impact on the world. As the pioneer of the life science real estate niche with our founding in 1994, Alexandria is the preeminent and longest-tenured owner, operator, and developer of collaborative mega campuses in AAA life science innovation cluster locations, including Greater Boston, the San Francisco Bay Area, San Diego, Seattle, Maryland, Research Triangle, and New York City. As of September 30, 2024, Alexandria has a total market capitalization of $33.1 billion and an asset base in North America that includes 41.8 million RSF of operating properties, 5.3 million RSF of Class A/A+ properties undergoing construction, and one committed near-term project expected to commence construction in the next two years. Alexandria has a longstanding and proven track record of developing Class A/A+ properties clustered in mega campuses that provide our innovative tenants with highly dynamic and collaborative environments that enhance their ability to successfully recruit and retain world-class talent and inspire productivity, efficiency, creativity, and success. Alexandria also provides strategic capital to transformative life science companies through our venture capital platform. We believe our unique business model and diligent underwriting ensure a high-quality and diverse tenant base that results in higher occupancy levels, longer lease terms, higher rental income, higher returns, and greater long-term asset value.
help-icon Live chat